Published in Neurogenetics on March 26, 2009
Epilepsy genetics in Africa: challenges and future perspectives. North Afr Middle East Epilepsy J (2015) 0.79
Neurogenomics in Africa: Perspectives, progress, possibilities and priorities. J Neurol Sci (2016) 0.78
Genetics of Lafora progressive myoclonic epilepsy: current perspectives. Appl Clin Genet (2016) 0.77
Genetics and genomic medicine in Mali: challenges and future perspectives. Mol Genet Genomic Med (2016) 0.75
Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A (1992) 61.33
Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet (2003) 2.00
Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc Natl Acad Sci U S A (2005) 1.90
Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG). J Biol Chem (2007) 1.57
Genetic diagnosis in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls. Neurology (2007) 1.53
Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway. Hum Mol Genet (2007) 1.42
Sweat gland duct cells in Lafora disease: diagnosis by skin biopsy. Neurology (1981) 1.20
Progressive myoclonus epilepsy with polyglucosans (Lafora disease): evidence for a third locus. Neurology (2004) 1.17
Lafora disease due to EPM2B mutations: a clinical and genetic study. Neurology (2005) 1.15
The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system. Hum Mol Genet (2008) 1.14
Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment. Hum Mol Genet (2007) 1.11
Clinical and genetic findings in 26 Italian patients with Lafora disease. Epilepsia (2006) 1.03
Progressive myoclonus epilepsies: EPM1, EPM2A, EPM2B. Adv Neurol (2005) 1.02
The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum Mol Genet (1995) 0.97
Progressive myoclonus epilepsy with Lafora inclusion bodies. II. Studies of ultrastructure. Arch Neurol (1967) 0.97
Late-onset and slow-progressing Lafora disease in four siblings with EPM2B mutation. Epilepsia (2005) 0.96
Skin biopsy in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls. Neurology (2003) 0.92
Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy. J Med Genet (2006) 0.90
Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin. Hum Mutat (2008) 0.88
Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population. J Hum Genet (2005) 0.88
Familial Lafora body disease of late onset: report of four cases in one family and a review of the literature. J Neurol (1997) 0.86
Typical progression of myoclonic epilepsy of the Lafora type: a case report. Nat Clin Pract Neurol (2008) 0.82
Lafora progressive myoclonus epilepsy: disease course homogeneity in a genetic isolate. J Child Neurol (2008) 0.78
Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy. J Hum Genet (2003) 0.77
[Late discovery of Lafora disease: a family study]. Rev Neurol (Paris) (2002) 0.77
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature (1991) 9.89
Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med (1988) 5.84
Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature (1985) 4.62
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell (1998) 4.07
Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science (1993) 3.99
Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron (1997) 3.73
The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature (1988) 2.75
Evidence of behaviour change following a hygiene promotion programme in Burkina Faso. Bull World Health Organ (2001) 2.47
Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann Neurol (2001) 2.29
Precision of reinnervation of original postsynaptic sites in frog muscle after a nerve crush. J Neurocytol (1976) 2.25
CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet (2000) 2.18
Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet (1992) 2.18
Trinucleotide repeats in neurogenetic disorders. Annu Rev Neurosci (1996) 2.17
Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene. Neurology (1989) 2.12
Complexities in the genetic structure of Anopheles gambiae populations in west Africa as revealed by microsatellite DNA analysis. Proc Natl Acad Sci U S A (1998) 2.06
Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci (1995) 1.95
Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol (1998) 1.93
Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab (2001) 1.91
Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci U S A (2001) 1.74
Dominant GDAP1 mutations cause predominantly mild CMT phenotypes. Neurology (2011) 1.67
Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases. J Inherit Metab Dis (2012) 1.66
Cerebellar atrophy in a patient with velocardiofacial syndrome. J Med Genet (1995) 1.64
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry (2010) 1.61
The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet (1992) 1.56
Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neurol (1997) 1.55
Thymosin beta4 accelerates wound healing. J Invest Dermatol (1999) 1.50
Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum Mol Genet (1998) 1.49
'Microalbuminuric anaemia'--the relationship between haemoglobin levels and albuminuria in diabetes. Diabetes Res Clin Pract (2009) 1.48
Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations. Hum Mol Genet (1997) 1.45
Acceleration of viral replication and up-regulation of cytokine levels by antimalarials: implications in malaria-endemic areas. Am J Trop Med Hyg (1999) 1.45
Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology (2003) 1.45
SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials. Neurology (2006) 1.44
Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen (1999) 1.40
Risk factors for trachoma in Mali. Int J Epidemiol (2002) 1.38
Altered trafficking of mutant connexin32. J Neurosci (1997) 1.33
Androgens regulate the mammalian homologues of invertebrate sex determination genes tra-2 and fox-1. Biochem Biophys Res Commun (2001) 1.32
Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol Dis (1997) 1.29
Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications. Ann Trop Med Parasitol (2003) 1.28
X-linked neuropathy: gene localization with DNA probes. Ann Neurol (1986) 1.27
Neurological manifestations of accidental hypothermia. Ann Neurol (1981) 1.25
Polyglutamine and CBP: fatal attraction? Nat Med (2001) 1.21
Trinucleotide repeat expansion in neurological disease. Ann Neurol (1994) 1.20
Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron (1994) 1.15
Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system. Neurobiol Dis (1997) 1.13
Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1. Neurology (2007) 1.13
Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara. J Virol (2002) 1.11
Recombination with pERT87 (DXS164) in families with X-linked muscular dystrophy. Lancet (1986) 1.09
Prevalence of blindness and visual impairment in the region of Ségou, Mali. A baseline survey for a primary eye care programme. Trop Med Int Health (1996) 1.08
[Cartography of trachoma in Mali: results of a national survey]. Bull World Health Organ (1998) 1.06
Molecular genetics of Charcot-Marie-Tooth disease and related neuropathies. Hum Mol Genet (1994) 1.06
Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice. Nat Genet (1995) 1.05
Duchenne muscular dystrophy gene expression in normal and diseased human muscle. Science (1988) 1.04
Ethnobotanical survey and antibacterial activity of some plants used in Guinean traditional medicine. J Ethnopharmacol (2007) 1.04
Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet (1996) 1.03
Hypothalamic hamartomas: with special reference to gelastic epilepsy and surgery. Neurosurgery (1994) 1.02
Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am J Pathol (1998) 1.02
Parieto-occipital grey matter abnormalities in children with Williams syndrome. Neuroimage (2005) 1.01
Cerebral toxoplasmosis in a patient with the acquired immunodeficiency syndrome presenting as obstructive hydrocephalus. Clin Neuropathol (1995) 1.01
Traditional couching is not an effective alternative procedure for cataract surgery in Mali. Ophthalmic Epidemiol (2000) 1.00
Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor. Cancer Res (2000) 0.99
[Clinical signs of severe malaria in a pediatric hospital in Ouagadougou]. Sante (1997) 0.99
Identification of complement receptor one (CR1) polymorphisms in west Africa. Genes Immun (2000) 0.98
Founder effect in spinal and bulbar muscular atrophy (SBMA). Hum Mol Genet (1996) 0.98
[Trichiasis surgery in the Koulikoro region of Mali. Performance and need]. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique (1997) 0.98
Generation and fluorescent in situ hybridization mapping of yeast artificial chromosomes of 1p, 17p, 17q, and 19q from a hybrid cell line by high-density screening of an amplified library. Genomics (1991) 0.98
Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost (2008) 0.97
A cell culture model for androgen effects in motor neurons. J Neurochem (1998) 0.96
Triplet repeat expansion in neuromuscular disease. Muscle Nerve (2000) 0.96
Segmental spinal muscular atrophy and dermatological findings in a patient with chromosome 18q deletion. Ann Neurol (1991) 0.95
Spinal and bulbar muscular atrophy: a trinucleotide-repeat expansion neurodegenerative disease. Trends Neurosci (1995) 0.95
A locus for axonal motor-sensory neuropathy with deafness and mental retardation maps to Xq24-q26. Genomics (1995) 0.95
Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93/637 (SA). Anticancer Res (2000) 0.94
A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4) localizes to a 500-kb interval on chromosome 9q34. Neurogenetics (2000) 0.94
Paroxysmal choreoathetosis associated with thyrotosicosis. Ann Neurol (1979) 0.94
Linkage localization of X-linked Charcot-Marie-Tooth disease. Am J Hum Genet (1993) 0.93
CAG repeat length variation in sperm from a patient with Kennedy's disease. Hum Mol Genet (1995) 0.93
Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability. Hum Mol Genet (1998) 0.93
The ecology and behaviour of the forest form of Anopheles gambiae s.s. Parassitologia (1993) 0.92
Variation and phylogenetic utility of the Arabidopsis thaliana Rps2 homolog in various species of the tribe Brassiceae. Mol Phylogenet Evol (2000) 0.92
Loss of heterozygosity on the short arm of chromosomes 1 and 3 in sporadic pheochromocytoma and extra-adrenal paraganglioma. Hum Pathol (1997) 0.91
Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease. Lancet (1998) 0.91
The elimination of the onchocerciasis vector from the island of Bioko as a result of larviciding by the WHO African Programme for Onchocerciasis Control. Acta Trop (2009) 0.91
A genetic linkage map of five marker loci in and around the Duchenne muscular dystrophy locus. Genomics (1989) 0.91
Familial autoimmune myasthenia gravis. Neurology (1994) 0.91
Picroliv preconditioning protects the rat liver against ischemia-reperfusion injury. Eur J Pharmacol (2000) 0.90
Estimation of the male and female mutation rates in Duchenne muscular dystrophy (DMD). Hum Genet (1992) 0.90
Protein kinase C gamma mutations in spinocerebellar ataxia 14 increase kinase activity and alter membrane targeting. Brain (2004) 0.90
Spinal and bulbar muscular atrophy: pathogenesis and clinical management. Oral Dis (2013) 0.89
Chronic tetanus: clinical report and histochemistry of muscle. Muscle Nerve (1981) 0.89
Diagnostic quality in rural health centres in Burkina Faso. Trop Med Int Health (1998) 0.89
Oculodentodigital dysplasia syndrome associated with abnormal cerebral white matter. Am J Med Genet (1991) 0.88
Normal serum iron and ferritin concentrations in patients with Friedreich's ataxia. Ann Neurol (1998) 0.88
Prevention of renal ischemia-reperfusion-induced injury in rats by picroliv. Biochem Pharmacol (2000) 0.88
Hereditary retinal vasculopathy with cerebral white matter lesions. Am J Med Genet (1989) 0.88
Assessment of maternal mortality and late maternal mortality among a cohort of pregnant women in Bamako, Mali. Br J Obstet Gynaecol (1999) 0.87
Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun (1994) 0.86
Facioscapulohumeral muscular dystrophy defect identified. Nat Genet (1992) 0.86
[Evaluation of the efficacity of coconut (Cocos nucifera), palm nut (Eleais guineensis) and gobi (Carapa procera) lotions and creams in indivirual protection against Simulium damnosum s.l. bites in Côte d'Ivoire]. Bull Soc Pathol Exot (2003) 0.85